Registration No. _________

                UNITED STATES SECURITIES AND EXCHANGE COMMISSION

                             Washington, D.C. 20549

                                    FORM S-8
             REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933

                       WEST PHARMACEUTICAL SERVICES, INC.
             (Exact name of registrant as specified in its charter)

  Pennsylvania                                         23-1210010
  (State or other jurisdiction              (I.R.S. Employer Identification No.)
   of incorporation or organization)

  101 Gordon Drive
  Lionville, Pennsylvania                                            19341
  (Address of Principal Executive Offices)                         (Zip Code)

                        2003 EMPLOYEE STOCK PURCHASE PLAN
                            (Full title of the plan)

                           John R. Gailey III, Esquire
                  Vice President, General Counsel and Secretary
                       West Pharmaceutical Services, Inc.
                                101 Gordon Drive
                          Lionville, Pennsylvania 19341
                     (Name and address of agent for service)

                                 (610) 594-3319
          (Telephone number, including area code of agent for service)

                         CALCULATION OF REGISTRATION FEE
<TABLE>
<CAPTION>
<S>                             <C>                    <C>                     <C>                      <C>


    ===================== ================= ======================== ========================== ===================

    Title of securities     Amount to be           Proposed                  Proposed               Amount of
      to be registered       Registered        maximum offering               maximum            registration fee
                                (1)           price per share (2)       aggregate offering
                                                                             price (2)
    --------------------- ----------------- ------------------------ -------------------------- -------------------
    Common Stock,
    Par value                1,500,000
    $.25 per share             Shares               $24.93                $37,395,000.00            $3,025.26
    ===================== ================= ======================== ========================== ===================
    (1)  This   Registration   Statement  also  registers  such  additional
         indeterminate  number of shares of Common Stock or other  securities as
         may  become  issuable  by  reason  of  the   anti-dilution   adjustment
         provisions of the 2003 Employee Stock Purchase Plan.

    (2)  Estimated solely for purposes of determining the registration fee in
         accordance with Rule 457(h) under the Securities Act of 1933 on the
         basis of $24.93 per share, the average of the high and low prices of
         the registrant's common stock, par value $.25 per share (the "Common
         Stock") as reported in the consolidated reporting system of the New
         York Stock Exchange on July 7, 2003.
</TABLE>

<PAGE>


Item 3.  Incorporation of Documents by Reference.

The following documents or information are incorporated by reference in this
registration statement:

(a)      The registrant's Annual Report on Form 10-K for the year ended
         December 31, 2002 (Commission File No. 1-8036).

(b)      The registrant's Quarterly Report on Form 10-Q for the fiscal quarter
         ended March 31, 2003 (Commission File No. 1-8036).

(c)      The description of the Common Stock contained in the registrant's
         Registration Statement on Form 8-A filed on October 17, 1980
         (Commission File No. 1-8036).

All documents subsequently filed by the registrant pursuant to Sections 13(a),
13(c), 14 and 15(d) of the Securities Exchange Act of 1934, as amended, prior to
the filing of a post-effective amendment which indicates that all securities
offered have been sold or which deregisters all securities then remaining
unsold, shall be deemed to be incorporated by reference in this Registration
Statement and to be a part hereof from the date of filing such documents.

Item 6.     Indemnification of Directors and Officers.

            The registrant maintains a policy of insurance under which the
respective directors and officers (as defined therein) of the registrant are
insured subject to specified exclusions and deductibles and retention and
maximum amounts against loss arising from any civil claim or claims which may be
made against any director or officer (as so defined) of the registrant by reason
of any breach of duty, neglect, error, misstatement, misleading statement,
omission or act done or wrongfully attempted or alleged to have been done while
acting in their respective capacities.

            Section 8 of Article II of the Bylaws of the registrant provides
that a director shall not be personally liable for monetary damages for any
action taken on or after January 27, 1987, or for failure to take any action on
or after such date unless (i) the director has breached or failed to perform the
duties of his office under Section 8363 of the Pennsylvania Directors Liability
Act (Act 145 of 1986, P.L. 1458), relating to standard of care and justifiable
reliance, and (ii) the breach or failure to perform constitutes self-dealing,
willful misconduct or recklessness. The provisions of Section 8 of Article II
shall not apply to (i) any criminal statute, or (ii) the liability of a director
for the payment of taxes due to local, state or federal law.

            Article IV of the Bylaws provides that the registrant shall
indemnify any person who was or is a party or threatened to be made a party to
any threatened, pending or completed action, suit or proceeding by reason of the
fact that such person is or was a director, officer, employee or agent of the
registrant or serving at the request of the registrant as a director, officer,
employee or agent of another entity. Such indemnification shall be against all
expenses, judgments, fines and amounts paid in settlement of such proceedings to
the extent that such person has not otherwise been indemnified and the power to
give such indemnification has been granted by statute. For this purpose, the
Board has the power to buy and maintain insurance at the registrant's expense.
Payment of expenses may be made to an indemnified person prior to the final
disposition of an action.

            The Pennsylvania Directors Liability Act and the Pennsylvania
Business Corporations Law authorize the indemnification set forth above if the
actions of the person to be indemnified did not constitute willful misconduct or
recklessness or, in the opinion of the registrant, self- dealing. The character
of the conduct of the person to be indemnified shall be determined by members of
the Board not parties to such litigation, independent counsel or the
shareholders of the registrant. The obligation of the registrant to indemnify a
director, officer, employee or agent under Article IV constitutes a contract
between the registrant and such person, and no modification or repeal of any
provision of Article IV will affect, to the detriment of the director, officer,
employee or agent such obligations of the registrant in connection with a claim
based in any act or failure to act occurring before such modification or repeal.

<PAGE>


Item 8.  Exhibits.

The following exhibits are filed herewith:

Exhibit No.                                       Description

     5                        Opinion of General Counsel regarding
                              legality of securities being registered

     23(a)                    Consent of PricewaterhouseCoopers LLP

     23(b)                    Consent of General Counsel
                              (contained in opinion filed as Exhibit 5)

     24                       Powers of Attorney


Item 9.      Undertakings

1.         The undersigned registrant hereby undertakes:

          (a) To file,  during  any  period  in which  offers or sales are being
              made, a post-effective amendment to this registration statement:

              (i) To include any prospectus  required by Section 10(a)(3) of the
              Securities Act of 1933;

              (ii) To  reflect  in the  prospectus  any facts or events  arising
              after the  effective  date of the  registration  statement (or the
              most recent post-effective amendment thereof) which,  individually
              or in  the  aggregate,  represent  a  fundamental  change  in  the
              information   set   forth   in   the    registration    statement.
              Notwithstanding the foregoing,  any increase or decrease in volume
              of  securities  offered (if the total dollar  value of  securities
              offered  would  not  exceed  that  which was  registered)  and any
              deviation  from  the  low or  high  end of the  estimated  maximum
              offering  range may be reflected in the form of  prospectus  filed
              with the Commission  pursuant to Rule 424(b) if, in the aggregate,
              the  changes  in  volume  and price  represent  no more than a 20%
              change in the maximum  aggregate  offering  price set forth in the
              "Calculation   of   Registration   Fee"  table  in  the  effective
              registration statement;

              (iii) To include any material information with respect to the plan
              of  distribution  not  previously  disclosed  in the  registration
              statement  or any  material  change  to  such  information  in the
              registration statement;

              Provided, however, that paragraphs (a)(i) and (a)(ii) above do not
              apply if the  registration  statement is on Form S-3,  Form S-8 or
              Form  F-3,  and  the  information  required  to be  included  in a
              post-effective  amendment  by those  paragraphs  is  contained  in
              periodic  reports filed with or furnished to the Commission by the
              registrant  pursuant  to  Section  13  or  Section  15(d)  of  the
              Securities Exchange Act of 1934 that are incorporated by reference
              in the registration statement.

          (b) That,  for the  purpose of  determining  any  liability  under the
          Securities Act of 1933,  each such  post-effective  amendment shall be
          deemed to be a new registration  statement  relating to the securities
          offered  therein,  and the  offering of such  securities  at that time
          shall be deemed to be the initial bona fide offering thereof.

<PAGE>


          (c) To remove from registration by means of a post-effective amendment
          any of the  securities  being  registered  which remain  unsold at the
          termination of the offering.

 2.  The undersigned registrant hereby undertakes that, for purposes of
     determining any liability under the Securities Act of 1933, each filing of
     the registrant's annual report pursuant to Section 13(a) or Section 15(d)
     of the Securities Exchange Act of 1934 (and, where applicable, each filing
     of an employee benefit plan's annual report pursuant to Section 15(d) of
     the Securities Exchange Act of 1934) that is incorporated by reference in
     the registration statement shall be deemed to be a new registration
     statement relating to the securities offered therein, and the offering of
     such securities at that time shall be deemed to be the initial bona fide
     offering thereof.

 3.  Insofar as indemnification for liabilities arising under the Securities Act
     of 1933 may be permitted to directors, officers and controlling persons of
     the registrant pursuant to the foregoing provisions, or otherwise, the
     registrant has been advised that in the opinion of the Securities and
     Exchange Commission such indemnification is against public policy as
     expressed in the Act and is, therefore, unenforceable. In the event that a
     claim for indemnification against such liabilities (other than the payment
     by the registrant of expenses incurred or paid by a director, officer or
     controlling person of the registrant in the successful defense of any
     action, suit or proceeding) is asserted by such director, officer or
     controlling person in connection with the securities being registered, the
     registrant will, unless in the opinion of its counsel the matter has been
     settled by controlling precedent, submit to a court of appropriate
     jurisdiction the question whether such indemnification by it is against
     public policy as expressed in the Act and will be governed by the final
     adjudication of such issue.




<PAGE>




                                   SIGNATURES

Pursuant to the requirements of the Securities Act of 1933, the registrant
certifies that it has reasonable grounds to believe that it meets all of the
requirements for filing on Form S-8 and has duly caused this registration
statement to be signed on its behalf by the undersigned, thereunto duly
authorized, in the Borough of Lionville, Commonwealth of Pennsylvania, on the
10th day of July, 2003.
                       WEST PHARMACEUTICAL SERVICES, INC.

                       /s/ J. R. Gailey

                       John R. Gailey III, Vice President

Pursuant to the requirements of the Securities Act of 1933, this registration
statement has been signed below by the following persons in the capacities and
on the dates indicated.
<TABLE>
<CAPTION>
<S>                                                                <C>                                  <C>


Signature                                                         Title                                 Date
----------------------------------------------- -------------------------------------------------- -----------------

/s/Donald E. Morel, Jr.                         Director, Chairman of the Board, President and
------------------------------------            Chief Executive Officer (principal executive
Donald E. Morel, Jr.                            officer)                                           July 10, 2003

/s/Linda R. Altemus                             Vice President and Chief Financial Officer
------------------------------------            (principal financial officer)                      July 10, 2003
Linda R. Altemus


/s/Joseph E. Abbott                             Vice President and Corporate Controller
------------------------------------            (principal accounting officer)                     July 10, 2003
Joseph E. Abbott

                  *                             Director
------------------------------------
Tenley E. Albright
                  *                             Director
------------------------------------
John W. Conway
                                                Director
------------------------------------
George W. Ebright
                  *                             Director
------------------------------------
L. Robert Johnson
                                                Director
------------------------------------
William H. Longfield
                  *                             Director
------------------------------------
John P. Neafsey
                                                Director
------------------------------------
Anthony Welters
                  *                             Director
------------------------------------
Geoffrey F. Worden
                  *                             Director
------------------------------------
* By:  /s/ JOHN R. GAILEY III
       ----------------------
        John R. Gailey III
        Attorney-in-Fact

                  *                             Director
------------------------------------
Robert C. Young
                  *                             Director
------------------------------------
Patrick J. Zenner

* By:  /s/ JOHN R. GAILEY III
       ----------------------
        John R. Gailey III
        Attorney-in-Fact
</TABLE>



<PAGE>




                                  Exhibit Index


         Exhibit No.                           Description

              5                Opinion of General Counsel regarding
                               legality of securities being registered.

            23(a)              Consent of PricewaterhouseCoopers LLP

            23(b)              Consent of Corporate Counsel
                               (contained in opinion filed as Exhibit 5)

             24                Powers of Attorney
[{"type": "S-8", "sequence": "1", "filename": "west_s8.txt", "secsgml_size_bytes": 16833}]
{"company-data": {"conformed-name": "WEST PHARMACEUTICAL SERVICES INC", "cik": "0000105770", "assigned-sic": "3060", "irs-number": "231210010", "state-of-incorporation": "PA", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "S-8", "act": "33", "file-number": "333-106977", "film-number": "03783962"}, "business-address": {"street1": "101 GORDON DR", "street2": "P O BOX 645", "city": "LIONVILLE", "state": "PA", "zip": "19341-0645", "phone": "6105942900"}, "mail-address": {"street1": "101 GORDON DRIVE", "street2": "PO BOX 645", "city": "LIONVILLE", "state": "PA", "zip": "19341-0645"}, "former-company": {"former-conformed-name": "WEST CO INC", "date-changed": "19990405"}}
Registration No. _________

                UNITED STATES SECURITIES AND EXCHANGE COMMISSION

                             Washington, D.C. 20549

                                    FORM S-8
             REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933

                       WEST PHARMACEUTICAL SERVICES, INC.
             (Exact name of registrant as specified in its charter)

  Pennsylvania                                         23-1210010
  (State or other jurisdiction              (I.R.S. Employer Identification No.)
   of incorporation or organization)

  101 Gordon Drive
  Lionville, Pennsylvania                                            19341
  (Address of Principal Executive Offices)                         (Zip Code)

                        2003 EMPLOYEE STOCK PURCHASE PLAN
                            (Full title of the plan)

                           John R. Gailey III, Esquire
                  Vice President, General Counsel and Secretary
                       West Pharmaceutical Services, Inc.
                                101 Gordon Drive
                          Lionville, Pennsylvania 19341
                     (Name and address of agent for service)

                                 (610) 594-3319
          (Telephone number, including area code of agent for service)

                         CALCULATION OF REGISTRATION FEE
===================== ================= ======================== ========================== ===================

    Title of securities     Amount to be           Proposed                  Proposed               Amount of
      to be registered       Registered        maximum offering               maximum            registration fee
                                (1)           price per share (2)       aggregate offering
                                                                             price (2)
    --------------------- ----------------- ------------------------ -------------------------- -------------------
    Common Stock,
    Par value                1,500,000
    $.25 per share             Shares               $24.93                $37,395,000.00            $3,025.26
    ===================== ================= ======================== ========================== ===================
    (1)  This   Registration   Statement  also  registers  such  additional
         indeterminate  number of shares of Common Stock or other  securities as
         may  become  issuable  by  reason  of  the   anti-dilution   adjustment
         provisions of the 2003 Employee Stock Purchase Plan.

    (2)  Estimated solely for purposes of determining the registration fee in
         accordance with Rule 457(h) under the Securities Act of 1933 on the
         basis of $24.93 per share, the average of the high and low prices of
         the registrant's common stock, par value $.25 per share (the "Common
         Stock") as reported in the consolidated reporting system of the New
         York Stock Exchange on July 7, 2003.
Item 3.  Incorporation of Documents by Reference.

The following documents or information are incorporated by reference in this
registration statement:

(a)      The registrant's Annual Report on Form 10-K for the year ended
         December 31, 2002 (Commission File No. 1-8036).

(b)      The registrant's Quarterly Report on Form 10-Q for the fiscal quarter
         ended March 31, 2003 (Commission File No. 1-8036).

(c)      The description of the Common Stock contained in the registrant's
         Registration Statement on Form 8-A filed on October 17, 1980
         (Commission File No. 1-8036).

All documents subsequently filed by the registrant pursuant to Sections 13(a),
13(c), 14 and 15(d) of the Securities Exchange Act of 1934, as amended, prior to
the filing of a post-effective amendment which indicates that all securities
offered have been sold or which deregisters all securities then remaining
unsold, shall be deemed to be incorporated by reference in this Registration
Statement and to be a part hereof from the date of filing such documents.

Item 6.     Indemnification of Directors and Officers.

            The registrant maintains a policy of insurance under which the
respective directors and officers (as defined therein) of the registrant are
insured subject to specified exclusions and deductibles and retention and
maximum amounts against loss arising from any civil claim or claims which may be
made against any director or officer (as so defined) of the registrant by reason
of any breach of duty, neglect, error, misstatement, misleading statement,
omission or act done or wrongfully attempted or alleged to have been done while
acting in their respective capacities.

            Section 8 of Article II of the Bylaws of the registrant provides
that a director shall not be personally liable for monetary damages for any
action taken on or after January 27, 1987, or for failure to take any action on
or after such date unless (i) the director has breached or failed to perform the
duties of his office under Section 8363 of the Pennsylvania Directors Liability
Act (Act 145 of 1986, P.L. 1458), relating to standard of care and justifiable
reliance, and (ii) the breach or failure to perform constitutes self-dealing,
willful misconduct or recklessness. The provisions of Section 8 of Article II
shall not apply to (i) any criminal statute, or (ii) the liability of a director
for the payment of taxes due to local, state or federal law.

            Article IV of the Bylaws provides that the registrant shall
indemnify any person who was or is a party or threatened to be made a party to
any threatened, pending or completed action, suit or proceeding by reason of the
fact that such person is or was a director, officer, employee or agent of the
registrant or serving at the request of the registrant as a director, officer,
employee or agent of another entity. Such indemnification shall be against all
expenses, judgments, fines and amounts paid in settlement of such proceedings to
the extent that such person has not otherwise been indemnified and the power to
give such indemnification has been granted by statute. For this purpose, the
Board has the power to buy and maintain insurance at the registrant's expense.
Payment of expenses may be made to an indemnified person prior to the final
disposition of an action.

            The Pennsylvania Directors Liability Act and the Pennsylvania
Business Corporations Law authorize the indemnification set forth above if the
actions of the person to be indemnified did not constitute willful misconduct or
recklessness or, in the opinion of the registrant, self- dealing. The character
of the conduct of the person to be indemnified shall be determined by members of
the Board not parties to such litigation, independent counsel or the
shareholders of the registrant. The obligation of the registrant to indemnify a
director, officer, employee or agent under Article IV constitutes a contract
between the registrant and such person, and no modification or repeal of any
provision of Article IV will affect, to the detriment of the director, officer,
employee or agent such obligations of the registrant in connection with a claim
based in any act or failure to act occurring before such modification or repeal.
Item 8.  Exhibits.

The following exhibits are filed herewith:

Exhibit No.                                       Description

     5                        Opinion of General Counsel regarding
                              legality of securities being registered

     23(a)                    Consent of PricewaterhouseCoopers LLP

     23(b)                    Consent of General Counsel
                              (contained in opinion filed as Exhibit 5)

     24                       Powers of Attorney

Item 9.      Undertakings

1.         The undersigned registrant hereby undertakes:

          (a) To file,  during  any  period  in which  offers or sales are being
              made, a post-effective amendment to this registration statement:

              (i) To include any prospectus  required by Section 10(a)(3) of the
              Securities Act of 1933;

              (ii) To  reflect  in the  prospectus  any facts or events  arising
              after the  effective  date of the  registration  statement (or the
              most recent post-effective amendment thereof) which,  individually
              or in  the  aggregate,  represent  a  fundamental  change  in  the
              information   set   forth   in   the    registration    statement.
              Notwithstanding the foregoing,  any increase or decrease in volume
              of  securities  offered (if the total dollar  value of  securities
              offered  would  not  exceed  that  which was  registered)  and any
              deviation  from  the  low or  high  end of the  estimated  maximum
              offering  range may be reflected in the form of  prospectus  filed
              with the Commission  pursuant to Rule 424(b) if, in the aggregate,
              the  changes  in  volume  and price  represent  no more than a 20%
              change in the maximum  aggregate  offering  price set forth in the
              "Calculation   of   Registration   Fee"  table  in  the  effective
              registration statement;

              (iii) To include any material information with respect to the plan
              of  distribution  not  previously  disclosed  in the  registration
              statement  or any  material  change  to  such  information  in the
              registration statement;

              Provided, however, that paragraphs (a)(i) and (a)(ii) above do not
              apply if the  registration  statement is on Form S-3,  Form S-8 or
              Form  F-3,  and  the  information  required  to be  included  in a
              post-effective  amendment  by those  paragraphs  is  contained  in
              periodic  reports filed with or furnished to the Commission by the
              registrant  pursuant  to  Section  13  or  Section  15(d)  of  the
              Securities Exchange Act of 1934 that are incorporated by reference
              in the registration statement.

          (b) That,  for the  purpose of  determining  any  liability  under the
          Securities Act of 1933,  each such  post-effective  amendment shall be
          deemed to be a new registration  statement  relating to the securities
          offered  therein,  and the  offering of such  securities  at that time
          shall be deemed to be the initial bona fide offering thereof.
(c) To remove from registration by means of a post-effective amendment
          any of the  securities  being  registered  which remain  unsold at the
          termination of the offering.

 2.  The undersigned registrant hereby undertakes that, for purposes of
     determining any liability under the Securities Act of 1933, each filing of
     the registrant's annual report pursuant to Section 13(a) or Section 15(d)
     of the Securities Exchange Act of 1934 (and, where applicable, each filing
     of an employee benefit plan's annual report pursuant to Section 15(d) of
     the Securities Exchange Act of 1934) that is incorporated by reference in
     the registration statement shall be deemed to be a new registration
     statement relating to the securities offered therein, and the offering of
     such securities at that time shall be deemed to be the initial bona fide
     offering thereof.

 3.  Insofar as indemnification for liabilities arising under the Securities Act
     of 1933 may be permitted to directors, officers and controlling persons of
     the registrant pursuant to the foregoing provisions, or otherwise, the
     registrant has been advised that in the opinion of the Securities and
     Exchange Commission such indemnification is against public policy as
     expressed in the Act and is, therefore, unenforceable. In the event that a
     claim for indemnification against such liabilities (other than the payment
     by the registrant of expenses incurred or paid by a director, officer or
     controlling person of the registrant in the successful defense of any
     action, suit or proceeding) is asserted by such director, officer or
     controlling person in connection with the securities being registered, the
     registrant will, unless in the opinion of its counsel the matter has been
     settled by controlling precedent, submit to a court of appropriate
     jurisdiction the question whether such indemnification by it is against
     public policy as expressed in the Act and will be governed by the final
     adjudication of such issue.
SIGNATURES

Pursuant to the requirements of the Securities Act of 1933, the registrant
certifies that it has reasonable grounds to believe that it meets all of the
requirements for filing on Form S-8 and has duly caused this registration
statement to be signed on its behalf by the undersigned, thereunto duly
authorized, in the Borough of Lionville, Commonwealth of Pennsylvania, on the
10th day of July, 2003.
                       WEST PHARMACEUTICAL SERVICES, INC.

                       /s/ J. R. Gailey

                       John R. Gailey III, Vice President

Pursuant to the requirements of the Securities Act of 1933, this registration
statement has been signed below by the following persons in the capacities and
on the dates indicated.
Signature                                                         Title                                 Date
----------------------------------------------- -------------------------------------------------- -----------------

/s/Donald E. Morel, Jr.                         Director, Chairman of the Board, President and
------------------------------------            Chief Executive Officer (principal executive
Donald E. Morel, Jr.                            officer)                                           July 10, 2003

/s/Linda R. Altemus                             Vice President and Chief Financial Officer
------------------------------------            (principal financial officer)                      July 10, 2003
Linda R. Altemus

/s/Joseph E. Abbott                             Vice President and Corporate Controller
------------------------------------            (principal accounting officer)                     July 10, 2003
Joseph E. Abbott

                  *                             Director
------------------------------------
Tenley E. Albright
                  *                             Director
------------------------------------
John W. Conway
                                                Director
------------------------------------
George W. Ebright
                  *                             Director
------------------------------------
L. Robert Johnson
                                                Director
------------------------------------
William H. Longfield
                  *                             Director
------------------------------------
John P. Neafsey
                                                Director
------------------------------------
Anthony Welters
                  *                             Director
------------------------------------
Geoffrey F. Worden
                  *                             Director
------------------------------------
* By:  /s/ JOHN R. GAILEY III
       ----------------------
        John R. Gailey III
        Attorney-in-Fact

                  *                             Director
------------------------------------
Robert C. Young
                  *                             Director
------------------------------------
Patrick J. Zenner

* By:  /s/ JOHN R. GAILEY III
       ----------------------
        John R. Gailey III
        Attorney-in-Fact
Exhibit Index

         Exhibit No.                           Description

              5                Opinion of General Counsel regarding
                               legality of securities being registered.

            23(a)              Consent of PricewaterhouseCoopers LLP

            23(b)              Consent of Corporate Counsel
                               (contained in opinion filed as Exhibit 5)

             24                Powers of Attorney